Ginkgo Bioworks Holdings (DNA) Operating Leases (2022 - 2025)
Historic Operating Leases for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Q3 2025 value amounting to $422.9 million.
- Ginkgo Bioworks Holdings' Operating Leases fell 509.93% to $422.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $422.9 million, marking a year-over-year decrease of 509.93%. This contributed to the annual value of $438.8 million for FY2024, which is 9778.93% up from last year.
- Latest data reveals that Ginkgo Bioworks Holdings reported Operating Leases of $422.9 million as of Q3 2025, which was down 509.93% from $428.8 million recorded in Q2 2025.
- In the past 5 years, Ginkgo Bioworks Holdings' Operating Leases registered a high of $452.3 million during Q2 2024, and its lowest value of $221.8 million during Q4 2023.
- In the last 4 years, Ginkgo Bioworks Holdings' Operating Leases had a median value of $418.1 million in 2022 and averaged $392.6 million.
- Its Operating Leases has fluctuated over the past 5 years, first crashed by 4632.02% in 2023, then surged by 9778.93% in 2024.
- Over the past 4 years, Ginkgo Bioworks Holdings' Operating Leases (Quarter) stood at $413.3 million in 2022, then tumbled by 46.32% to $221.8 million in 2023, then soared by 97.79% to $438.8 million in 2024, then fell by 3.62% to $422.9 million in 2025.
- Its Operating Leases stands at $422.9 million for Q3 2025, versus $428.8 million for Q2 2025 and $434.6 million for Q1 2025.